About SciAnalytical

The Partner of Choice for Pharma, Biotech and Clinical Industries

 

Top ten reasons to work with SciAnalytical Strategies

  1. Unparalleled scientific reputation and leadership in field of bioanalytical chemistry

  2. SciAnalytical is your Analytical Department, we are your analytical partner, not a “CRO”

  3. Science-Driven

  4. Quality and Integrity

  5. Track record of success

  6. Local / SoCal

  7. Industry-Leading turn-around time on studies

  8. Cost competitive

  9. Flexible, Responsive

  10. Partnering Philosophy:  Biotech start-ups, pharma that do not have internal analytical chemistry/bioanalytical chemistry

 

Management Team BioSketch

Dr. Kassel founded SciAnalytical Strategies in 2013, a bioanalytical, biomarker discovery and consulting firm that serves the pharmaceutical, biotechnology and clinical industries

 

Previously, Dr. Kassel served as Vice President of Analytical Sciences and DMPK at Takeda (2005-2012). There, he led teams in the areas of high throughput analysis, mass directed purification, DMPK and biomarker discovery and development. He also led several discovery research projects for Takeda, most notably an insulin-sparing oral therapy for Type 1 diabetes.  Dr. Kassel played a key role, was awarded the Takeda Global award in 2008, for his work on Alogliptin, marketed in Japan and the U.S. for the treatment of Type 2 diabetes. He was also an invited participant in the Takeda Leadership Institute—the most prestigious leadership program within Takeda.  Dr. Kassel received his PhD from Michigan State University and was awarded an NIH NRSA fellowship at Harvard University.  He has authored over 70 peer-reviewed manuscripts and more than 100 abstracts, taught numerous short courses and workshops on mass spectrometry and drug discovery.